Author Elakad, Omar
-
2019 | Journal Article |
Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer
Buentzel, J. ; Yao, S.; Elakad, O.; Lois, A.-M.; Brünies, J.; König, J. & Hinterthaner, M. et al. (2019)
Medicine, 98(31) art. e16712. DOI: https://doi.org/10.1097/MD.0000000000016712
Details DOI PMID PMC
-
2020 | Journal Article |
Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer
Elakad, O.; Lois, A.; Schmitz, K.; Yao, S.; Hugo, S.; Lukat, L. & Hinterthaner, M. et al. (2020)
Cancer Medicine, 9(10) pp. 3574-3583. DOI: https://doi.org/10.1002/cam4.2994
Details DOI
-
2020 | Journal Article |
UDP-glucose 6-dehydrogenase expression as a predictor of survival in patients with pulmonary adenocarcinoma
Saha, S.; Yao, S.; Elakad, O.; Lois, A.-M.; Henric-Petri, H.; Buentzel, J. & Hinterthaner, M. et al. (2020)
International Journal of Surgery. Oncology, 5(2) art. e85. DOI: https://doi.org/10.1097/IJ9.0000000000000085
Details DOI
-
2021 | Journal Article
Role of Annexin A1 in Squamous Cell Lung Cancer Progression
Elakad, O.; Li, Y.; Gieser, N.; Yao, S.; Küffer, S. ; Hinterthaner, M. & Danner, B. C. et al. (2021)
Disease Markers, 2021 pp. 1-10. DOI: https://doi.org/10.1155/2021/5520832
Details DOI
-
2021 | Journal Article | Research Paper |
One carbon metabolism in human lung cancer
Yao, S.; Peng, L.; Elakad, O.; Küffer, S. ; Hinterthaner, M. ; Danner, B. C. & Hammerstein-Equord, A. von et al. (2021)
Translational Lung Cancer Research, 10(6) pp. 2523-2538. DOI: https://doi.org/10.21037/tlcr-20-1039
Details DOI
-
2022 | Journal Article
Low expression of CD24 is associated with poor survival in colorectal cancer
Nersisyan, S.; Ahlers, A.-K.; Lange, T.; Wicklein, D.; Galatenko, A.; Bohnenberger, H. & Elakad, O. et al. (2022)
Biochimie, 192 pp. 91-101. DOI: https://doi.org/10.1016/j.biochi.2021.10.004
Details DOI
-
2022 | Journal Article | Research Paper |
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis
Bremer, S. C. B. ; Bittner, G.; Elakad, O.; Dinter, H.; Gaedcke, J. ; König, A. O. & Amanzada, A. et al. (2022)
Cancers, 14(12) pp. 2828. DOI: https://doi.org/10.3390/cancers14122828
Details DOI
-
2022 | Journal Article |
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
Elakad, O.; Häupl, B.; Labitzky, V.; Yao, S.; Küffer, S. ; von Hammerstein-Equord, A. & Danner, B. et al. (2022)
npj Precision Oncology, 6(1). DOI: https://doi.org/10.1038/s41698-022-00296-2
Details DOI
-
2022 | Journal Article | Research Paper |
Expression and prognostic impact of CD49b in human lung cancer
Tirilomi, A.; Elakad, O.; Yao, S.; Li, Y.; Hinterthaner, M. ; Danner, B. C. & Ströbel, P. et al. (2022)
Medicine, 101(6) art. e28814. DOI: https://doi.org/10.1097/MD.0000000000028814
Details DOI PMID PMC
-
2022 | Journal Article | Research Paper |
Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma
Li, Y.; Elakad, O.; Yao, S.; von Hammerstein-Equord, A.; Hinterthaner, M. ; Danner, B. C. & Ferrai, C. et al. (2022)
Metabolites, 12(7). DOI: https://doi.org/10.3390/metabo12070652
Details DOI